Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Free Cash Flow (2019 - 2025)

Silo Pharma (SILO) has disclosed Free Cash Flow for 7 consecutive years, with -$780278.0 as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 14.95% to -$780278.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.7 million through Dec 2025, down 21.58% year-over-year, with the annual reading at -$4.7 million for FY2025, 21.58% down from the prior year.
  • Free Cash Flow hit -$780278.0 in Q4 2025 for Silo Pharma, up from -$955493.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$319318.0 in Q1 2021 to a low of -$1.6 million in Q1 2025.
  • Historically, Free Cash Flow has averaged -$874769.4 across 5 years, with a median of -$813672.0 in 2022.
  • Biggest five-year swings in Free Cash Flow: plummeted 171.51% in 2021 and later increased 29.04% in 2025.
  • Year by year, Free Cash Flow stood at -$773871.0 in 2021, then fell by 14.49% to -$885989.0 in 2022, then fell by 2.71% to -$910012.0 in 2023, then dropped by 0.82% to -$917432.0 in 2024, then increased by 14.95% to -$780278.0 in 2025.
  • Business Quant data shows Free Cash Flow for SILO at -$780278.0 in Q4 2025, -$955493.0 in Q3 2025, and -$1.3 million in Q2 2025.